Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ORGANIZATION
ORGANIZATION
- NPO Asks MHLW to Take Steps to Ensure Proper Use of Xeplion
June 23, 2016
- PMDA Chief Brings Together Drug Makers, Tech Vendors to Compile Proposal on Digital Health
June 17, 2016
- Re-Pricing Rules Need Drastic Overhaul, Possible Abolishment Should Be Discussed for Z2: FPMAJ
June 14, 2016
- FPMAJ Report Warns of Repercussions from Sovaldi Price Slash
June 14, 2016
- Reimbursement Prices Kept Unchanged for Over 20% of Drugs: FPMAJ Survey
June 13, 2016
- FPMAJ Wants to Avoid Narrowing-Down of Premium-Eligible Products: Kamoya
June 13, 2016
- FPMAJ Drug Pricing Affairs Chief Lashes Out at Proposed Out-of-Cycle Re-Pricing
June 13, 2016
- 9 Pharma-Related Companies to Join to Global Health Innovative Technology Fund
June 8, 2016
- Japan Is at Crossroads, Must Carry On Its Pro-Innovation Policies: PhRMA Chairman
June 3, 2016
- PhRMA Still “Concerned” about Anti-Innovation Policies despite Tax Decision: Japan Chief
June 2, 2016
- Biosimilar Policies Shouldn’t Threaten Biologics Development: EFPIA Japan
May 31, 2016
- Astellas’s Hatanaka Elected as New JPMA President
May 27, 2016
- Sumitomo Dainippon Pres. Tada Picked as New Chief of FPMAJ
May 27, 2016
- No Need to Add Hep B Vaccines to Public Immunization Program: Drug Damage Watchdog
May 13, 2016
- Citizen’s Group Says Kaketsuken Shouldn’t Profit from Suspension-Cleared Products, Surcharges Needed
May 13, 2016
- EFPIA Takes to Nagata-cho to Call for Real Dialogue
April 28, 2016
- National Univ. Hospital Council to Disclose Funding with Companies’ Names Not Affiliated with JPMA
April 27, 2016
- JPMA Official Calls for Use of Academic Data in Drug Submissions
April 26, 2016
- Quakes Injure 3, Cause Property Damage for 22 Companies: JPMA Survey
April 20, 2016
- JPMA Sets Up Taskforce for Russia, Brazil, Mexico, Turkey
April 18, 2016
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…